ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,039.44
      1.09%
      US Tech 100
      21,188.40
      -0.05%
      Dow Jones
      43,306.18
      0.02%
      Brent Oil
      72.865
      -0.57%
      Bitcoin
      95,633.75
      -3.69%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Tango Therapeutics Inc (TNGX) Quote

      Tango Therapeutics Inc

      Tango Therapeutics Inc (TNGX)

      NASDAQ
      3.10
      0.06
      ( 1.97% )
      Updated: 14:26:35
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      3.10
      Bid
      3.09
      Ask
      3.10
      Volume
      299,162
      2.96 Day's Range 3.13
      2.70 52 Week Range 13.005
      Market Cap
      332.995M
      Previous Close
      3.04
      Open
      3.05
      Last Trade
      1
      @
      3.1
      Last Trade Time
      14:27:14
      Financial Volume
      $ 919,690
      VWAP
      3.0742
      Average Volume (3m)
      2,016,604
      Shares Outstanding
      107,417,818
      Dividend Yield
      -
      PE Ratio
      -3.25
      Earnings Per Share (EPS)
      -0.95
      Revenue
      36.53M
      Net Profit
      -101.74M

      About Tango Therapeutics Inc

      Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.tangotx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was $3.04. Over the last year, Tango Therapeutics shares have traded in a share price range of $ 2.70 to $ 13.005.

      Tango Therapeutics currently has 107,417,818 shares outstanding. The market capitalization of Tango Therapeutics is $326.55 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -3.25.

      Ask ADVFN Intelligence (AI)

      TNGX Latest News

      More News

      Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

      December 03 2024
      Business Wire

      Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

      Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

      November 27 2024
      Business Wire

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      November 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 18 2024
      Edgar (US Regulatory)

      Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

      November 07 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 06 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 06 2024
      Edgar (US Regulatory)

      Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

      – Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program moving into full development with multiple combination studies – – Clinical collaboration...

      November 06 2024
      Business Wire

      Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

      – TNG462 demonstrated durable clinical activity across multiple tumor types, including non-small cell lung cancer (NSCLC) and pancreatic cancer, in ongoing phase 1/2 clinical trial, moving into...

      November 06 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.3111.11111111112.793.282.71526401233.01092928CS
      4-0.92-22.88557213934.024.212.715374623.14929626CS
      12-3.77-54.87627365366.877.46462.720166044.04132863CS
      26-6.04-66.08315098479.1412.0152.714062675.81234672CS
      52-7.07-69.518190757110.1713.0052.710316716.9094935CS
      156-7.85-71.689497716910.9513.032.477161117.1064052CS
      260-6.51-67.74193548399.6118.842.476592607.33220346CS

      TNGX - Frequently Asked Questions (FAQ)

      What is the current Tango Therapeutics share price?
      The current share price of Tango Therapeutics is $ 3.10
      How many Tango Therapeutics shares are in issue?
      Tango Therapeutics has 107,417,818 shares in issue
      What is the market cap of Tango Therapeutics?
      The market capitalisation of Tango Therapeutics is USD 326.55M
      What is the 1 year trading range for Tango Therapeutics share price?
      Tango Therapeutics has traded in the range of $ 2.70 to $ 13.005 during the past year
      What is the PE ratio of Tango Therapeutics?
      The price to earnings ratio of Tango Therapeutics is -3.25
      What is the cash to sales ratio of Tango Therapeutics?
      The cash to sales ratio of Tango Therapeutics is 9.06
      What is the reporting currency for Tango Therapeutics?
      Tango Therapeutics reports financial results in USD
      What is the latest annual turnover for Tango Therapeutics?
      The latest annual turnover of Tango Therapeutics is USD 36.53M
      What is the latest annual profit for Tango Therapeutics?
      The latest annual profit of Tango Therapeutics is USD -101.74M
      What is the registered address of Tango Therapeutics?
      The registered address for Tango Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Tango Therapeutics website address?
      The website address for Tango Therapeutics is www.tangotx.com
      Which industry sector does Tango Therapeutics operate in?
      Tango Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AIREreAlpha Tech Corporation
      $ 3.1599
      (130.65%)
      		117.71M
      SPRCSciSparc Ltd
      $ 0.5031
      (127.44%)
      		226.36M
      MGIHMillennium Group International Holdings Ltd
      $ 3.30
      (115.69%)
      		73.51M
      ZCARZoomcar Holdings Inc
      $ 2.6513
      (85.41%)
      		57.17M
      SKKSKK Holdings Limited
      $ 1.281
      (71.26%)
      		49.43M
      LNKSLinkers Industries Ltd
      $ 4.30
      (-55.16%)
      		2.42M
      BAOSBaosheng Media Group Holdings Ltd
      $ 4.32
      (-39.15%)
      		1.63M
      NEUPNeuphoria Therapeutics Inc
      $ 4.50
      (-32.13%)
      		518k
      GTIGraphjet Technology
      $ 0.4244
      (-30.43%)
      		16.45M
      SVRESaverOne 2014 Ltd
      $ 1.10
      (-27.15%)
      		1.21M
      SPRCSciSparc Ltd
      $ 0.5031
      (127.44%)
      		226.36M
      XTIAXTI Aerospace Inc
      $ 0.04
      (2.04%)
      		215.99M
      COEPCoeptis Therapeutics Holdings Inc
      $ 0.2059
      (45.00%)
      		195.1M
      RGTIRigetti Computing Inc
      $ 14.53
      (28.02%)
      		167.16M
      SMXSMX Security Matters Public Company
      $ 0.334
      (53.21%)
      		161.79M

      TNGX Discussion

      View Posts
      Monksdream Monksdream 6 months ago
      TNGX under $10
      👍️0
      Monksdream Monksdream 8 months ago
      TNGX under $10
      👍️0
      bikaver bikaver 1 year ago
      Stopped out with small loss.
      👍️0
      bikaver bikaver 1 year ago
      TNGX......Holding up well, but will tumble soon.
      👍️0
      bikaver bikaver 1 year ago
      TNGA.....short @ 8.60 This is the strength that I wanted to see!
      👍️0
      bikaver bikaver 1 year ago
      TNGX.....Studying the TNGX chart this evening. I'll short it at a good sign of strength if the opportunity presents itself tomorrow.
      👍️0
      SmokeSignals SmokeSignals 1 year ago
      up $4>H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
      Barclays Releases a Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
      Goldman Sachs Keeps Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 7, 2023TIPRANKS
      Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business HighlightsAUGUST 7, 2023TIPRANKS
      Tango Therapeutics reports Q2 EPS (23c), consensus (34c)AUGUST 7, 2023TIPRANKS
      👍️0

      Your Recent History

      NASDAQ
      TNGX
      Tango Therapeutics
      LSE
      CLA
      Celsius Resources
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads